EP3363901

FRED HUTCHINSON CANCER CENTER
Application Number
EP18150361A
Filing Date
Feb 15, 2013
Status
Granted And Under Opposition
Nov 27, 2020
Grant Date
Dec 30, 2020
External Links
Slate, Register

Biblio Summary

The patent EP3363901B1 was granted on Dec 30, 2020 by Fred Hutchinson Cancer Center The patent is currently Granted And Under Opposition.

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUNECKER PATENT- UND RECHTSANWALTE PARTG MBBSep 30, 2021ADMISSIBLE
JAMES POOLE LIMITEDSep 30, 2021ADMISSIBLE
STRAWMAN LIMITEDSep 30, 2021ADMISSIBLE

The table below shows the patents of Fred Hutchinson Cancer Center that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3688157High Efficiency Targeted In Situ Genome-Wide ProfilingApr 27, 20221
EP3636778Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)Jan 12, 20222
EP2689010Method And Compositions For Cellular ImmunotherapyNov 18, 20201

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.